Bronchogen is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Bronchogen is being researched for inflammation applications. Operates through gene expression modulation — interacts with DNA regulatory sequences and histone proteins in lung cells to reduce pro-inflammatory cytokines, promote regeneration of bronchial epithel. Common dosages for this use range from 200 mcg daily once daily.
Can Bronchogen Help With Inflammation?
Bronchogen (Tetrapeptide Ala-Glu-Asp-Leu (AEDL)) is being researched for inflammation applications based on its mechanism as a Peptide bioregulator.
Operates through gene expression modulation — interacts with DNA regulatory sequences and histone proteins in lung cells to reduce pro-inflammatory cytokines, promote regeneration of bronchial epithelium, and restore ciliated cell populations. Also enhances local mucosal immunity by increasing secretory IgA.
What Does the Research Show for Bronchogen and Inflammation?
One-month administration in COPD animal models eliminated bronchial remodeling symptoms including goblet cell hyperplasia, squamous metaplasia, and lymphocytic infiltration. Increased secretory IgA and surfactant protein B levels. Research remains preclinical.
The relevance to inflammation specifically comes from Bronchogen's effects on respiratory epithelial repair, reduced mucus hypersecretion, inflammation reduction, improved ciliary function, enhanced mucosal immunity.
What Protocol Is Used for Inflammation?
For inflammation applications, the standard Bronchogen protocol is 200 mcg daily administered once daily via subcutaneous injection for 28-30 days.
Some researchers adjust dosing based on the specific inflammation application — see our Bronchogen dosage guide for full protocol details.
Can Stacking Improve Inflammation Results?
Complements respiratory support protocols with LL-37 (antimicrobial) and VIP (bronchodilation) for comprehensive lung health.
What Side Effects Apply to Inflammation Use?
No reported adverse effects in animal models. Human safety data unavailable. Generally well-tolerated with no systemic toxicity observed in preclinical studies.
Side effects are generally consistent regardless of the specific application. See our Bronchogen side effects guide for details.
Calculate Your Bronchogen Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Bronchogen.
Open Calculator →Bottom Line: Bronchogen for Inflammation
Bronchogen shows preliminary research potential for inflammation. Standard protocols (200 mcg daily, once daily, 28-30 days) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
Bronchogen : Benefits, Dosage, Side Effects & Research
Related Reading
- Bronchogen Dosage Guide
- Bronchogen Benefits
- Bronchogen Side Effects
- Bronchogen Stacking Guide
- Bronchogen Cycle Guide
- Bronchogen Research
Research-Grade Sourcing
If you're going to research Bronchogen, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Bronchogen?
Bronchogen (Tetrapeptide Ala-Glu-Asp-Leu (AEDL)) is a Peptide bioregulator. Synthetic tetrapeptide derived from lung tissue extracts, designed to modulate bronchial epithelial cell function. It is researched for respiratory epithelial repair, reduced mucus hypersecretion, inflammation reduction, improved ciliary function, enhanced mucosal immunity.
What is the recommended Bronchogen dosage?
Common dosages: 200 mcg daily administered once daily via subcutaneous injection. Cycle length: 28-30 days. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of Bronchogen?
No reported adverse effects in animal models. Human safety data unavailable. Generally well-tolerated with no systemic toxicity observed in preclinical studies.
Is Bronchogen safe?
Bronchogen has shown a favorable safety profile in research. Not FDA-approved. Research compound only. Available as investigational peptide in some European countries. All research should follow appropriate safety protocols.